What is AI Medicine Software?
AI is commonly used in medical science for the diagnosis process, end-to-end drug discovery and development, remote patient monitoring, transcribing medical documents, etc. The new technology AI and machine learning play a vital role in end-to-end drug development as it requires reading a huge amount of data from various sources including research papers, patient records, images, genes, symptoms, diseases, proteins, tissues, and many more. The healthcare facilities are also focusing on improving patient care by reducing medical errors and personalized medicines, which is expected to accelerate the market growth in the nearer future.
The market study is broken down, by Application (Diagnosis Processes, Treatment Protocol Development, Drug Development, Personalized Medicine and Patient Monitoring & Care) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global AI Medicine Software market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
IBM (United States), Oncora Medical (United States), Babylon Health (United Kingdom), Arterys (United States), CloudMedx (United States), Corti (Denmark), Sophia Genetics (Switzerland), Enlitic (United States), Caption Health (United States), 3M (United States), OSP (United States), Microsoft Corporation (United States), GNS Healthcare (United States), Carta Healthcare (United States), Ada Health (Germany), Sirona Medical (United States) and Promaton (Netherlands) are some of the key players that are part of study coverage.
AdvanceMarketAnalytics has segmented the market of Global AI Medicine Software market by Type, Application and Region.
On the basis of geography, the market of AI Medicine Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Enterprise Size, the sub-segment i.e. Small and Medium Enterprises will boost the AI Medicine Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Deployment, the sub-segment i.e. Cloud will boost the AI Medicine Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-user, the sub-segment i.e. Hospitals will boost the AI Medicine Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Integration of NLP Enabled Chatbot Technologies with the AI systems to create a Virtual Interventional Radiologist (VIR)
- Surging Demand for Advanced Technologies to Eliminate Medical Errors and Improve Quality of Patient Care
- Increasing Use of AI and Machine Learning for the New Drug Development and Increase Efficiency of Diagnosis Processes
- The Standardization of Hospital Administration to Improve Management Decisions and Remote Monitoring of Patients
- Possibility of Inaccuracy and Rising Security Concerns Due to Increasing Number of Cyberattacks in the Healthcare Sector
- High Cost of Software and Requirement of Extensively Trained Staff
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, AI Medicine Software Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations, End-Users and Others
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):
1. What all players are profiled in the study?
The standard version of the report profiles players such as IBM (United States), Oncora Medical (United States), Babylon Health (United Kingdom), Arterys (United States), CloudMedx (United States), Corti (Denmark), Sophia Genetics (Switzerland), Enlitic (United States), Caption Health (United States), 3M (United States), OSP (United States), Microsoft Corporation (United States), GNS Healthcare (United States), Carta Healthcare (United States), Ada Health (Germany), Sirona Medical (United States) and Promaton (Netherlands) etc.
2. Can we have customized study for AI Medicine Software Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
3. What would be the Market Size of AI Medicine Software Market by 2027?
Analysts at AMA estimates AI Medicine Software Market to reach USD Million by 2027.